Meet the IMPACT Steering Committee

Following is a list of members of the IMPACT Steering Committee. By clicking on each of their names you will be able to access a brief description of that member's background and research interests:

Chief Investigator
 Dr Ros Eeles, Reader in Clinical  Cancer Genetics & Hon Consultant in Cancer Genetics & Oncology, The Institute of Cancer Research (ICR) & The Royal Marsden NHS Foundation Trust (RMH), UK.

IMPACT coordinators
Dr Anita Mitra, Clinical Research Fellow, ICR, UK.

Miss Elizabeth Bancroft, Research Nurse, ICR and RMH, UK. 

Statistician
 Professor Doug Easton, Cancer Research UK Genetic Epidemiology Unit, Cambridge, UK.
 

Dr Yolanda Barbachano, RMH, UK

Other Investigators:

Mrs Audrey Ardern-Jones, Senior Clinical Nurse Specialist and Genetic Counsellor, RMH, UK.

Prof  Chris Bangma, Professor and Chairman of the Department of Urology, Erasmus Universiteit, The Netherlands.

Professor David Dearnaley, Head of Urology Unit, RMH, UK.

Professor Diana Eccles, Consultant in Clinical Genetics, Wessex Clinical Genetics Service, Princess Anne Hospital, Southampton, UK.

Professor Gareth Evans, Consultant Clinical Geneticist, Regional Genetics Service, St Mary’s Hospital, Manchester, UK.

Professor Jorunn Eyfjord, Head of Molecular Genetics, Icelandic Cancer Society, Reykjavik, Iceland.

Dr Alison Falconer, Consultant in Clinical Oncology, Charing Cross Hospital, London, UK.

Professor Christopher Foster, Professor of Cellular and Molecular Pathology, Royal Liverpool University Hospital, Liverpool, UK.

Professor Henrik Grönberg, Karolinska Institute, Stockholm, Sweden.

Professor Freddie Hamdy, Nuffield Professor of Surgery and Professor of Urology, University of Oxford, John Radcliffe Hospital, Oxford, UK.

Dr Óskar Þór Jóhannsson, University Hospital of Iceland, Iceland.

Dr Vincent Khoo, Consultant Clinical Oncologist, RMH, UK.

Dr Zsofia Kote-Jarai, Staff Scientist, ICR, UK.

Professor Hans Lilja, Attending Research Clinical Chemist, Memorial Sloan-Kettering Cancer Center, USA.

Professor Jan Lubinski, Consultant Clinical Geneticist, International Hereditary Cancer Centre, Pomeranian Medical Univeristy, Poland.

Dr Lovise Maehle, Department of Cancer Genetics, Norwegian Radium Hospital, Oslo, Norway.

Dr Jane Melia, Team Leader in Epidemiology, ICR, UK.

Dr Gillian Mitchell, Peter MacCallum Cancer Centre, Melbourne, Australia.

Ms Clare Moynihan, Sociologist, ICR, UK.

Dr Susan Peock, EMBRACE Study Co-ordinator, Strangeways Research Laboratories, Cambridge, UK

Dr Gad Rennert, Director, CHS National Cancer Control Centre, Israel.

Professor Fritz Schröder, Department of Urology, Erasmus Universiteit, The Netherlands.

Dr Paul Sibley, Siemens Healthcare Diagnostics, UK.

Dr Mohnish Suri, Consultant Clinical Geneticist, Nottingham City Hospital. Nottingham, UK.

Dr Penny Wilson, Biotechnology and Healthcare Consultant, UK.

 Patient Reptesentative, RMH, UK.